Suheung Co., Ltd. (008490) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Suheung Co., Ltd. (008490:KRX), powered by AI.

Current Price
₩19,340
P/E Ratio
5.1
Market Cap
223.7B
Sector
Healthcare
What is the Suheung Co., Ltd. stock price forecast?

Suheung Co., Ltd. is currently trading at ₩19,340. View real-time AI analysis on Alpha Lenz.

What is Suheung Co., Ltd. insider trading activity?

View the latest insider trading data for Suheung Co., Ltd. on Alpha Lenz.

What is Suheung Co., Ltd.'s P/E ratio?

Suheung Co., Ltd.'s P/E ratio is 5.1.

Suheung Co., Ltd.

KRX · 008490
₩19,340+590(+3.15%)Market closedKRX regular session 09:00–15:30 KST
Ask about Suheung Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Suheung Co., Ltd. trades at a P/E of 5.1 (undervalued) with solid ROE of 9.2%.

Ask for details

Company Overview

Suheung Co., Ltd. is a prominent player in the pharmaceutical industry, primarily engaged in the manufacturing and distribution of empty hard gelatin capsules. These capsules are crucial components of the pharmaceutical and nutraceutical sectors, serving as the primary shell for a variety of medicines and dietary supplements. With a focus on quality and innovation, Suheung emphasizes the production of capsules that cater to various formulation needs, including gelatin, HPMC (Hydroxypropyl methylcellulose) for vegetarians, and others geared towards specific pharmaceutical applications. The company’s operations have a significant impact on the healthcare and pharmaceutical industries, as its products are essential for drug delivery systems. Suheung Co., Ltd. holds a strong market position thanks to its commitment to technological advancements and meeting stringent quality standards. Its manufacturing processes and global distribution channels ensure a steady supply to major markets worldwide, underscoring its role as a reliable partner in the pharmaceutical supply chain. Established in South Korea, Suheung continues to expand its presence by continuously upgrading its manufacturing capabilities and adhering to international regulatory standards.

CEO양주환
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
Employees742

Company Statistics

FY 2025

Profile

₩223,746,645,420Market Cap
₩722,308,593,840Revenue
11.57MShares Out
742Employees

Margins

17.92%Gross
15.58%EBITDA
7.02%Operating
7.44%Pre-Tax
6.53%Net

Valuation

5.14P/E
0.46P/B
0.31EV/Sales
5.89EV/EBITDA
7.56P/FCF

Growth (CAGR)

4.39%Rev 3Yr
5.49%Rev 5Yr
-6.48%Op Inc 3Yr
-7.36%Op Inc 5Yr
5.11%Net Inc 3Yr
-4.47%Net Inc 5Yr

Returns

4.54%ROA
9.22%ROE
6.87%ROIC

Financial Health

₩48,157,831,020Cash & Cash Equivalents
₩471,961,014,700Net Debt
96.14%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Suheung Co., Ltd. (ticker: 008490) is a company listed on KRX in the Healthcare sector (Drug Manufacturers - Specialty & Generic). It has approximately 742 employees. Market cap is $223.7B.

The current price is ₩19,340 with a P/E ratio of 5.14x and P/B of 0.46x.

ROE is 9.22% and operating margin is 7.02%. Annual revenue is $722.3B.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Suheung Co., Ltd. (008490) Stock Forecast 2026 ₩19,340 — Price, Financials & Analyst Targets | Alpha Lenz